Cocaine withdrawal happens when a person who uses a lot of cocaine stops using cocaine. It can also happen when a person who uses a lot of cocaine starts using less cocaine than they did before.
Side effects of cocaine[change | change source]
- Increased body temperature (high fever)
- Irregular heart rate or rapid heart rate
- High blood pressure
- Increased risk of heart attack
- Sudden death from cardiac arrest
- Sudden aggression
- Sudden very bad paranoia
- Feeling, seeing, or hearing things that are not really there (hallucinations), including feeling like there are insects under the skin (this is called formication or coke bugs)
Withdrawal effects of cocaine[change | change source]
After using cocaine regularly, some users will become addicted. When a person who is used to using cocaine stops right away, they will go through what is called a "crash" along with many of other cocaine withdrawal symptoms, like:
- Exhaustion (feeling very tired)
- Mood swings (quick changes in emotions)
- Irritability (feeling easily annoyed)
- Fatigue (feeling tired), sleeping many hours
- Insomnia (trouble sleeping)
- A very strong craving for more cocaine
- Nausea and vomiting.
Some cocaine users also report having similar symptoms to schizophrenia patients and feel that their mind is lost. Some users also report formication: feeling like things are crawling on the skin (also called, "coke bugs" or "spiders"). These symptoms can last for weeks or, in some cases, months.
Even after many withdrawal symptoms go away, most users feel like they need to keep using cocaine. This feeling can last for years and may get worse during times of stress. About 30-40% of cocaine addicts start using other kinds of drugs or alcohol after they stop using cocaine.[better source needed]
Treatment[change | change source]
Therapy[change | change source]
Twelve-step programs like Cocaine Anonymous (modeled on Alcoholics Anonymous and Narcotics Anonymous) have been widely used to help people addicted to cocaine. Cognitive Behavioral Therapy (CBT) and Motivational Therapy (MT) have proven to be more helpful than 12-step programs in treating cocaine dependency. However, both of these approaches have a fairly low success rate.
Medications[change | change source]
Several drugs have been used to treat cocaine withdrawal and cravings:
- The anti-convulsant drug carbamazepine (Tegretol);
- Medicines which increase the amount of dopamine in the brain, like L-DOPA/carbidopa
- Amino acids
Reward-based treatments[change | change source]
On February 14, 2011, two Swiss psychologists published two years' research on cocaine addiction. They found that addicts who gambled were less likely to use cocaine or to relapse on cocaine. They think gambling may refocus the brain's "reward center" from cocaine to gambling. They said that psychotherapy should be used along with gambling. More research is being done on long-term relapse rates (the number of people who eventually start using cocaine again).[better source needed]
However, a more recent study looked at prize-based contingency management: a treatment method that offers addicts chances to win prizes if they do not use cocaine. This study found that prize-based contingency management helped cocaine addicts stay off cocaine, whether or not they had gambled recently. This suggests that it is the chance of a reward, not the gambling itself, that helps cocaine addicts stay off of cocaine.
References[change | change source]
-  ←Page #928 (4th page of article) ¶4. §(1), (2) & (3); Lines 10—12 & 15—18 of aforementioned 4th ¶.
- Walsh, Karen (October 2010). "Teen Cocaine Use". Cite journal requires
- Gawin, F.H. (1991). "Cocaine addiction: Psychology and neurophysiology". Science. 251 (5001): 1580–6. Bibcode:1991Sci...251.1580G. doi:10.1126/science.2011738. PMID 2011738.
- "Models of Intervention and Care for Psychostimulant Users, 2nd Edition – Monograph Series No. 51: The Cocaine Withdrawal Syndrome". The Department of Health. Government of Australia. April 2004.
- Brady KT, Lydiard RB, Malcolm R, Ballenger JC (1991). "Cocaine-induced psychosis". J Clin Psychiatry. 52: 509–512.
- Thirthalli J.; Vivek B. (2006). "Psychosis Among Substance Users". Curr Opin Psychiatry. 19 (3): 239–245. doi:10.1097/01.yco.0000218593.08313.fd.
- Elliott A.; Mahmood T.; Smalligan R.D. (2012). "Cocaine Bugs: A Case Report of Cocaine-Induced Delusions of Parasitosis". The American Journal on Addictions. 21: 180–181. doi:10.1111/j.1521-0391.2011.00208.x.
- "Cocaine Withdrawal". Treatment4Addiction Online Recovery Resource Directory. AAC.
- "Cognitive behavioural therapy reduced cocaine abuse compared with 12 step facilitation". ebmh.bmj.com. 17 January 2008. Retrieved 25 August 2012.
- Koenig, X; Hilber, K (29 January 2015). "The anti-addiction drug ibogaine and the heart: A delicate relation". Molecules (Basel, Switzerland). 20 (2): 2208–28. doi:10.3390/molecules20022208. PMC 4382526. PMID 25642835.
- Brown, Thomas (March 2013). "Ibogaine in the treatment of substance dependence". Current Drug Abuse Reviews. 6 (1): 3–16. doi:10.2174/15672050113109990001. PMID 23627782.
- Hegarty, Stephanie (April 13, 2012). "Can a hallucinogen from Africa cure addiction?". BBC World Service. British Broadcasting Corporation.
- Margolin, Arthur (2 January 2002). "Acupuncture for the treatment of cocaine addiction: A randomized controlled trial". The Journal of the American Medical Association. 287 (1). Cite has empty unknown parameter:
- Otto, Katharine C.; Quinn, Colin; Sung, Yung-Fong (Spring 1998). "Auricular acupuncture as an adjunctive treatment for cocaine addiction: A pilot study". The American Journal on Addictions. 7 (2): 164–170. doi:10.1111/j.1521-0391.1998.tb00331.x. PMID 9598220.
- Page, R.A.; Handleya, G.W. (1993). "The use of hypnosis in cocaine addiction". American Journal of Clinical Hypnosis. 36 (2): 120–123. doi:10.1080/00029157.1993.10403054. PMID 8259763.
- Potter, Greg (2004). "Intensive therapy: Utilizing hypnosis in the treatment of substance abuse disorders". American Journal of Clinical Hypnosis. 47 (1): 21–28. doi:10.1080/00029157.2004.10401472. PMID 15376606.
- Schaler, Jeffrey A. (September–October 1991). "Drugs and free will". Society. 28 (6): 42–49. doi:10.1007/BF02695758.
- Barbara, John; Morrison, June (January 1975). "If addiction is incurable, why do we try to cure it?: A comparison of control methods in the U.K. and the U.S". Crime & Delinquency. 21 (1): 28–33. doi:10.1177/001112877502100104.
- Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ; Larowe; Hedden; Kalivas; Malcolm (March 2007). "An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study". Prog. Neuropsychopharmacol. Biol. Psychiatry. 31 (2): 389–94. doi:10.1016/j.pnpbp.2006.10.001. PMID 17113207.CS1 maint: multiple names: authors list (link)
- LaRowe SD, Myrick H, Hedden S (July 2007). "Is cocaine desire reduced by N-acetylcysteine?". Am J Psychiatry. 164 (7): 1115–7. doi:10.1176/appi.ajp.164.7.1115. PMID 17606664.
- Gass JT, Olive MF; Olive (January 2008). "Glutamatergic substrates of drug addiction and alcoholism". Biochem. Pharmacol. 75 (1): 218–65. doi:10.1016/j.bcp.2007.06.039. PMC 2239014. PMID 17706608.
- Karila L, Gorelick D, Weinstein A (May 2008). "New treatments for cocaine dependence: a focused review". Int. J. Neuropsychopharmacol. 11 (3): 425–38. doi:10.1017/S1461145707008097. PMID 17927843.
- Ling W, Shoptaw S, Majewska D; Shoptaw; Majewska (May 1998). "Baclofen as a cocaine anti-craving medication: a preliminary clinical study". Neuropsychopharmacology. 18 (5): 403–4. doi:10.1016/S0893-133X(97)00128-0. PMID 9536455.CS1 maint: multiple names: authors list (link)
- Margolin A, Kosten TR, Avants SK (December 1995). "A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients". Drug Alcohol Depend. 40 (2): 125–31. doi:10.1016/0376-8716(95)01198-6. PMID 8745134.
- Cherstniakova SA, Bi D, Fuller DR, Mojsiak JZ, Collins JM, Cantilena LR; Bi; Fuller; Mojsiak; Collins; Cantilena (September 2001). "Metabolism of vanoxerine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, by human cytochrome P450 enzymes". Drug Metab. Dispos. 29 (9): 1216–20. PMID 11502731.CS1 maint: multiple names: authors list (link)
- Douglas Quenqua (3 October 2011). "An Addiction Vaccine, Tantalizingly Close". The New York Times.
- Kosten, M.D., Thomas; Sofuoglu, M.D., Ph.D., Mehmet;; et al. (January 2, 2005). "Desipramine Treatment for Cocaine Dependence in Buprenorphine- or Methadone-Treated Patients: Baseline Urine Results as a Predictor of Response". The American Journal on Addictions. 14 (1): 8–17. doi:10.1080/10550490590899817.CS1 maint: extra punctuation (link) CS1 maint: multiple names: authors list (link)
- Dursteler, Kenneth M.; Berger, Eva-Maria;; et al. (June 17, 2015). "Clinical potential of methylphenidate in the treatment of cocaine addiction: A review of the current evidence". Substance Abuse and Rehabilitation. Dovepress. 6: 61–74. doi:10.2147/SAR.S50807. Unknown parameter
|pmc=suggested) (help)CS1 maint: extra punctuation (link) CS1 maint: multiple names: authors list (link)
- Margolin, Arthur; Avants, S. Kelly; and Kosten, Thomas R. (1996). "Pemoline for the Treatment of Cocaine Dependence in Methadone-Maintained Patients". Journal of Psychoactive Drugs. 28 (3): 301–304. doi:10.1080/02791072.1996.10472491.CS1 maint: multiple names: authors list (link)
- Reisser, A. Lima; Lima, M.S.;; et al. (April 22, 2002). "Carbamazepine for cocaine dependence". The Cochrane Library. doi:10.1002/14651858.CD002023. Missing or empty
|url=(help)CS1 maint: extra punctuation (link) CS1 maint: multiple names: authors list (link)
- Rosen, Hugo; Flemenbaum, Abraham; and Slater, Victor L. (November 1986). "Clinical trial of carbidopa-(l)-dopa combination for cocaine abuse". The American Journal of Psychiatry. 143 (11). doi:10.1176/ajp.143.11.1493a.CS1 maint: multiple names: authors list (link)
- Chadwick, Michael J.; Gregory, David L.; and Wendling, Glenda (1990). "A Double-Blind Amino Acids, L-Tryptophan and L-Tyrosine, and Placebo Study with Cocaine-Dependent Subjects in an Inpatient Chemical Dependency Treatment Center". The American Journal of Drug and Alcohol Abuse. 16 (3–4): 275=286. doi:10.3109/00952999009001589.CS1 maint: multiple names: authors list (link)
- Chemistry, Design, and Structure-Activity Relationship of Cocaine Antagonists. Satendra Singh | display-authors = etal Chem. Rev. 2000, 100. 925-1024. PubMed; Chemical Reviews (Impact Factor: 45.66). 04/2000; 100(3):925-1024 American Chemical Society; 2000, ISSN 0009-2665 ChemInform; May, 16th 2000, Volume 31, Issue 20, DOI: 10.1002/chin.200020238. Mirror hotlink.
- Thema, Zum (February 13, 2011). "Reiz gegen Reiz ins Rennen schicken". der Standard (in German). Standard Verlagsgesellschaft m.b.H. 2016.
- Moore, Nich (February 15, 2011). "Swiss Docs Prove Blackjack Casino Gambling Best Cure for Cocaine Users". Blackjack Champ.
- Petry, Ph.D., Nancy M.; Alessi, Ph.D., Sheila M. (October 2010). "Prize-based contingency management is efficacious in cocaine-abusing patients with and without recent gambling participation". Journal of Substance Abuse Treatment. Elsevier. 39 (3): 282–288. doi:10.1016/j.jsat.2010.06.011.CS1 maint: multiple names: authors list (link)